BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension

By afschroeder • August 30, 2025

Sahay S, Palevsky H, El-Kersh K, Restrepo-Jaramillo R, Bajwa AA, Desai S, Joly JM, Spikes LA, Eggert MS, Johri S, Shapiro SM, Fisher MR, Shah TG, Ramani GV, Mehta JP, Thrasher CM, Deng C, Smith P, Broderick M, Burger CD. BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension. Respir Med. 2025 Aug 27;248:108318. doi: 10.1016/j.rmed.2025.108318. Epub ahead of print. PMID: 40882760.

Tags: Cardiology/Epi, Dry powder inhaler, exercise capacity, Prostacyclin dosing, Publications, pulmonary arterial hypertension, Treprostinil, Veterans Administration

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes

Lee L, Cao S, Miles CB, Troy MP, Moriarty JM. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Patient Selection, Procedural Pearls, and Expected Outcomes.[...]

Case Report: Exercise-associated changes of leukocyte gene expression in statin-associated myopathy

Bondar G, Mahapatra AD, Silacheva I, Bao TM, Vu T, Su S, Hairapetian A, Katappagari A, Galan L, Chandran J, Adamov R, Yang A, Bukkapatnam[...]

Program Directors Survey on Competency Assessment in Cardiology Fellowship

Cullen MW, Yang EH, Soukoulis V, Keating FK, Abudayyeh I, Kondapaneni M, Polk DM, Theriot P, Damp JB, Weissman G. Program Directors Survey on Competency[...]